CGP 77675 |
| Catalog No.GC18438 |
CGP 77675 es un inhibidor potente y activo por vía oral de las quinasas de la familia Src. CGP 77675 inhibe la fosforilación de sustratos peptídicos y la autofosforilación de Src purificada (IC50 de 5-20 y 40 nM, respectivamente), y también inhibe Src, EGFR, KDR, v-Abl y Lck con IC50 de 5-20, 40, 20 , 150, 1000, 310 y 290 nM, respectivamente. Actividad anticancerígena.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 234772-64-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CGP 77675 is an inhibitor of Src family kinases (SFKs) that blocks the phosphorylation of peptide substrates and autophosphorylation of purified c-Src (IC50s = 5-20 and 40 nM, respectively). It also inhibits the SFKs Lck and c-Yes with low nanomolar IC50 values. CGP 77675 is used to elucidate the role of SFKs in such processes as bone resorption, tight junction formation in epithelial cells, and allograft survival. It can also be used in combination with the GSK3 inhibitor CHIR99021 to maintain mouse embryonic stem cells.
Review for CGP 77675
Average Rating: 5 (Based on Reviews and 34 reference(s) in Google Scholar.)
Review for CGP 77675
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *